Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Mondi · SciRah

Researcher profile · Semantic Scholar

A. Mondi

Share profile

A. Mondi — researcher profile on SciRah

h-index: 24
Works: 94
Citations: 2,355

Most-cited papers

Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022
A. Antinori, V. Mazzotta, S. Vita, F. Carletti +55 more
2022Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin442 citations Open access
Semantic Scholar
Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding
D. Lapa, F. Carletti, V. Mazzotta, G. Matusali +21 more
2022Lancet. Infectious Diseases (Print)204 citations Open access
Semantic Scholar
National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
E. Nicastri, N. Petrosillo, T. A. Bartoli, L. Lepore +8 more
2020Infectious Disease Reports173 citations Open access
Semantic Scholar
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study
M. Prosperi, M. Fabbiani, I. Fanti, M. Zaccarelli +6 more
2012BMC Infectious Diseases97 citations Open access
Semantic Scholar
Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study
C. Agrati, A. Cossarizza, V. Mazzotta, G. Grassi +21 more
2022Lancet. Infectious Diseases (Print)88 citations Open access
Semantic Scholar
Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
F. Di Gennaro, G. Gualano, L. Timelli, P. Vittozzi +16 more
2021Antibiotics88 citations Open access
Semantic Scholar
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)
S. Di Giambenedetto, M. Fabbiani, Eugenia Quiros Roldan, A. Latini +17 more
2017Journal of Antimicrobial Chemotherapy75 citations Open access
Semantic Scholar
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
M. Rotger, Tracy R. Glass, Thomas Junier, J. Lundgren +71 more
2013Clinical Infectious Diseases75 citations Open access
Semantic Scholar
Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort
A. Mondi, A. Cozzi-Lepri, A. Tavelli, S. Rusconi +8 more
2019Journal of the International AIDS Society64 citations Open access
Semantic Scholar
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, At
S. Di Giambenedetto, M. Fabbiani, M. Colafigli, N. Ciccarelli +10 more
2013Journal of Antimicrobial Chemotherapy52 citations Open access
Semantic Scholar
COVID‐19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS‐CoV‐2
A. Mondi, E. Cimini, F. Colavita, S. Cicalini +17 more
2020Journal of Medical Virology48 citations Open access
Semantic Scholar
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study.
A. Mondi, M. Fabbiani, N. Ciccarelli, M. Colafigli +6 more
2015Journal of Antimicrobial Chemotherapy42 citations Open access
Semantic Scholar
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study
V. Mazzotta, A. Lepri, G. Matusali, E. Cimini +84 more
2024EClinicalMedicine37 citations Open access
Semantic Scholar
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial
M. Fabbiani, R. Gagliardini, N. Ciccarelli, Eugenia Quiros Roldan +167 more
2018Journal of Antimicrobial Chemotherapy34 citations Open access
Semantic Scholar
Antiretroviral Neuropenetration Scores Better Correlate with Cognitive Performance of HIV-Infected Patients after Accounting for drug Susceptibility
M. Fabbiani, P. Grima, Benedetta Milanini, A. Mondi +6 more
2015Antiviral Therapy34 citations Open access
Semantic Scholar
Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection
F. Colavita, V. Mazzotta, G. Rozera, I. Abbate +17 more
2023iScience33 citations Open access
Semantic Scholar
Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV
I. Mastrorosa, C. Pinnetti, A. Brita, A. Mondi +13 more
2022Clinical Infectious Diseases32 citations Open access
Semantic Scholar
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study)
M. Fabbiani, A. Mondi, M. Colafigli, G. d'Ettorre +10 more
2014Scandinavian Journal of Infectious Diseases30 citations
Semantic Scholar
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox
V. Mazzotta, A. Cozzi-Lepri, S. Lanini, A. Mondi +17 more
2023Journal of Medical Virology28 citations Open access
Semantic Scholar
Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications.
C. Pinnetti, E. Cimini, V. Mazzotta, G. Matusali +20 more
2023Lancet. Infectious Diseases (Print)27 citations Open access
Semantic Scholar
MPXV DNA kinetics in bloodstream and other body fluids samples
S. Meschi, F. Colavita, F. Carletti, V. Mazzotta +17 more
2024Scientific Reports25 citations Open access
Semantic Scholar
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment
G. Lapadula, D. Bernasconi, S. Casari, F. Maggiolo +13 more
2016PLoS ONE25 citations Open access
Semantic Scholar
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE)
Benedetta Milanini, N. Ciccarelli, M. Fabbiani, E. Baldonero +8 more
2016Clinical Neuropsychologist25 citations
Semantic Scholar
Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital
A. Mondi, P. Lorenzini, C. Castilletti, R. Gagliardini +183 more
2021International Journal of Infectious Diseases24 citations Open access
Semantic Scholar
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
A. Mondi, R. Gagliardini, V. Mazzotta, S. Vita +17 more
2022Journal of Infection23 citations Open access
Semantic Scholar
Impact of ART on dynamics of growth factors and cytokines in primary HIV infection.
V. Bordoni, A. Sacchi, R. Casetti, E. Cimini +6 more
2019Cytokine23 citations
Semantic Scholar
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy.
A. Borghetti, G. Baldin, A. Ciccullo, R. Gagliardini +10 more
2016Journal of Antimicrobial Chemotherapy23 citations
Semantic Scholar
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late for HIV diagnosis - results from the Icona cohort in Italy, 2009-2022.
A. Mondi, A. Cozzi-Lepri, A. Tavelli, A. Cingolani +12 more
2024International Journal of Infectious Diseases22 citations Open access
Semantic Scholar
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients
M. Fabbiani, M. Zaccarelli, P. Grima, M. Prosperi +8 more
2014BMC Infectious Diseases20 citations Open access
Semantic Scholar
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance
E. Baldonero, N. Ciccarelli, M. Fabbiani, M. Colafigli +6 more
2013BMC Psychology20 citations Open access
Semantic Scholar
Myeloid Derived Suppressor Cells Expansion Persists After Early ART and May Affect CD4 T Cell Recovery
C. Agrati, Nicola Tumino, V. Bordoni, C. Pinnetti +10 more
2019Frontiers in Immunology19 citations Open access
Semantic Scholar
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the Icona network.
A. Giacomelli, R. Gagliardini, A. Tavelli, S. De Benedittis +16 more
2023International Journal of Infectious Diseases18 citations Open access
Semantic Scholar
Temporal intra‐host variability of mpox virus genomes in multiple body tissues
M. Rueca, F. Tucci, V. Mazzotta, G. Gramigna +16 more
2023Journal of Medical Virology18 citations Open access
Semantic Scholar
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000–14
L. Fabeni, C. Alteri, D. Di Carlo, N. Orchi +26 more
2017Journal of Antimicrobial Chemotherapy18 citations Open access
Semantic Scholar
HIV MDR is still a relevant issue despite its dramatic drop over the years.
D. Armenia, D. Di Carlo, P. Flandre, Y. Bouba +24 more
2020Journal of Antimicrobial Chemotherapy17 citations Open access
Semantic Scholar
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study).
M. Camici, R. Gagliardini, Simone Lanini, Giulia Del Duca +24 more
2023International Journal of Antimicrobial Agents16 citations Open access
Semantic Scholar
The impact of DAA‐mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort
A. Bandera, P. Lorenzini, L. Taramasso, A. Cozzi-Lepri +161 more
2021Journal of Viral Hepatitis16 citations Open access
Semantic Scholar
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy
L. Fabeni, C. Alteri, G. Berno, R. Scutari +26 more
2019Sexually Transmitted Infections16 citations Open access
Semantic Scholar
Simplification to atazanavir/ritonavir plus lamivudine versus maintaining atazanavir/ritonavir+2NRTIs in virologically suppressed HIV-infected patients: 96-week data of the ATLAS-M trial
R. Gagliardini, M. Fabbiani, E. Roldán, A. Latini +17 more
201616 citations
Semantic Scholar
Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.
P. Grima, M. Fabbiani, N. Ciccarelli, M. Tana +5 more
2012Journal of Infection16 citations
Semantic Scholar
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial
M. Fabbiani, S. Di Giambenedetto, E. Quiros-Roldan, A. Latini +16 more
2014Journal of the International AIDS Society14 citations Open access
Semantic Scholar
Pharmacokinetic of Tecovirimat in subjects with Mpox.
M. Tempestilli, A. Mondi, A. D'Avolio, Olindo Forini +13 more
2023International Journal of Antimicrobial Agents13 citations Open access
Semantic Scholar
Simplification to a dual regimen with darunavir/ritonavir plus lamivudine or emtricitabine in virologically-suppressed HIV-infected patients.
M. Fabbiani, S. Di Giambenedetto, A. Poli, A. Borghetti +8 more
2016Journal of Infection12 citations
Semantic Scholar
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015–21
L. Fabeni, Daniele Armenia, Isabella Abbate, R. Gagliardini +74 more
2024Journal of Antimicrobial Chemotherapy11 citations Open access
Semantic Scholar
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH
R. Gagliardini, A. Vergori, P. Lorenzini, S. Cicalini +20 more
2022Journal of Clinical Medicine11 citations Open access
Semantic Scholar
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients
R. Gagliardini, M. Fabbiani, M. Colafigli, A. D'Avino +6 more
2017Journal of chemotherapy11 citations
Semantic Scholar
Kinetics of TTV Loads in Peripheral Blood Mononuclear Cells of Early Treated Acute HIV Infections
I. Abbate, G. Rozera, E. Cimini, F. Carletti +13 more
2023Viruses10 citations Open access
Semantic Scholar
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA.
B. Rossetti, G. Meini, C. Bianco, S. La Monica +7 more
2017Journal of Clinical Virology10 citations
Semantic Scholar
Evolution of SARS‐CoV‐2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID‐19 in an Italian reference hospital: Impact on clinical outcomes
A. Mondi, I. Mastrorosa, P. Piselli, C. Cimaglia +33 more
2023Journal of Medical Virology9 citations Open access
Semantic Scholar
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study.
Antonella d'Arminio Monforte, A. Tavelli, M. Sala, A. Mondi +8 more
2023Journal of Antimicrobial Chemotherapy9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Antinori×32
Invite
A. Antinori — researcher profile on SciRah
R. Gagliardini×28
Invite
R. Gagliardini — researcher profile on SciRah
C. Pinnetti×25
Invite
C. Pinnetti — researcher profile on SciRah
V. Mazzotta×20
Invite
V. Mazzotta — researcher profile on SciRah

S. Di Giambenedetto

×19

Invite

S. Di Giambenedetto — researcher profile on SciRah

Invite

F. Vaia — researcher profile on SciRah

M. Fabbiani×17

Invite

M. Fabbiani — researcher profile on SciRah

M. Colafigli×16

Invite

M. Colafigli — researcher profile on SciRah

Invite

R. Cauda — researcher profile on SciRah

E. Nicastri×15

Invite

E. Nicastri — researcher profile on SciRah

Invite

A. Vergori — researcher profile on SciRah

Invite

A. De Luca — researcher profile on SciRah